Shree PacetronixBOM:527005 +9.19%84 ROA % is 17.29% as of Mar. 2026, which is 522% above its 10-year median of 2.78. GuruFocus rates BOM:527005 with a GF Score™ of 84/100 and a GF Value™ of ₹163.29 (Fairly Valued). Among 857 Medical Devices & Instruments companies, Shree Pacetronix ranks better than 91.95% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Shree Pacetronix's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹44.5 Mil.
Shree Pacetronix's average Total Assets over the quarter that ended in Mar. 2026 was ₹257.1 Mil. Therefore, Shree Pacetronix's annualized ROA % for the quarter that ended in Mar. 2026 was 17.29%.
The historical rank and industry rank for Shree Pacetronix's ROA % or its related term are showing as below:
BOM:527005'
s ROA % Range Over the Past 10 Years
Min: -3.72 Med: 2.78 Max: 22.7
Current: 12.72
During the past 13 years, Shree Pacetronix's highest ROA % was 22.70%. The lowest was -3.72%. And the median was 2.78%.
BOM:527005's ROA % is ranked better than 91.95% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.55
vs BOM:527005: 12.72
Shree Pacetronix (BOM:527005) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Shree Pacetronix ROA % Related Terms
Shree Pacetronix ROA % Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's ROA % distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Shree Pacetronix (BOM:527005) has a ROA % of 17.29% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shree Pacetronix and its competitors. This is 522% above median its historical median of 2.78. According to the industry distribution chart, Shree Pacetronix ranks #69 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 8.1%.
Is Shree Pacetronix's ROA % too high?
Shree Pacetronix's current ROA % of 17.29% is 522% above median its 10-year median of 2.78. The Medical Devices & Instruments industry median ROA % is 0.55. Shree Pacetronix's value of 17.29% is 3043.6% above this industry median. Based on the distribution chart, Shree Pacetronix ranks #69 out of 857 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shree Pacetronix has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shree Pacetronix ranks #69 out of 857 companies for ROA %. This places Shree Pacetronix in the top 8% of its industry — outperforming the majority of peers. The industry median ROA % is 0.55. Shree Pacetronix's value of 17.29% is 3043.6% above this benchmark. While the company's 10-year median is 2.78 vs. the industry median of 0.55, Shree Pacetronix has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.55, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shree Pacetronix's current ROA % of 17.29% is 3043.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Shree Pacetronix and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shree Pacetronix's current ROA % is 17.29%, which is 522% above median its own 10-year median of 2.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Fairly Valued. The stock's GF Value™ is ₹163.29, compared to a current price of ₹152.05 — trading 6.9% below its estimated fair value. The current ROA % is 17.29%, which is 522% above median its 10-year median of 2.78 and 3043.6% above the Medical Devices & Instruments industry median of 0.55. Shree Pacetronix's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current ROA % is 17.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹152.05 is trading 6.9% below its estimated GF Value™ of ₹163.29.
GuruFocus considers Shree Pacetronix to be Fairly Valued.
Key valuation signals for BOM:527005:
ROA %: 17.29% (522% above median its 10-year median of 2.78)
GF Value™: ₹163.29 vs. price of ₹152.05 (6.9% below fair value)
Industry Position: 3043.6% above the Medical Devices & Instruments median (#69 of 857)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
84GF Score
Get the complete analysis for BOM:527005
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
